AGYTF News and Press, Allergy Therapeutics Plc

iClick Interactive Asia Group Limited (ICLK) is expected to report for quarter end 2023-09-30 Applied Minerals Inc (AMNL) is expected to report for quarter end 2023-09-30 Banco Do Brasil S.A. ADR (BDORY) is expected to report for Q3 2023 Rubius Therapeutics Inc. (RUBY) is expected to ...

Uni Charm Corporation ADR (UNICY) is expected to report for Q2 2023 Clarus Therapeutics Hldgs (CRXTQ) is expected to report for quarter end 2023-06-30 Bed Bath & Beyond Inc. (BBBYQ) is expected to report for Q2 2024 CalAmp Corp. (CAMP) is expected to report $-0.04 for Q2 2024 ...

Allergy Therapeutics Plc (AGYTF) is expected to report for quarter end 2023-06-30

New York City, NY: April 14, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Birch Pollen Allergy Drug Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is...

UK-based Allergy Therapeutics ( OTCPK:AGYTF ) announces the publication of positive data on its peanut allergy vaccine candidate in The Journal of Allergy and Clinical Immunology. More news on: Allergy Therapeutics plc, Aimmune Therapeutics, Inc., DBV Technologies S.A., Healthcare sto...

The following slide deck was published by Allergy Therapeutics Plc. in conjunction with their 2018 Q2 earnings Read more ...

Allergy Therapeutics ( OTCPK:AGYTF ): 1H EPS of 0.99p. More news on: Allergy Therapeutics Plc., Earnings news and commentary, Consumer stocks news, , Read more ...